Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cengild Medical Bhd's Other Operating Expense for the
three
months ended in Mar. 2026 was RM-0.65 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was RM-3.39 Mil.
Cengild Medical Bhd's quarterly Other Operating Expense
increased
from Sep. 2025 (RM-0.94 Mil) to Dec. 2025 (RM-0.76 Mil) and
increased
from Dec. 2025 (RM-0.76 Mil) to Mar. 2026 (RM-0.65 Mil).
Cengild Medical Bhd's annual Other Operating Expense
increased
from Jun. 2023 (RM0.00 Mil) to Jun. 2024 (RM0.00 Mil) but then
declined
from Jun. 2024 (RM0.00 Mil) to Jun. 2025 (RM-0.00 Mil).
Cengild Medical Bhd Other Operating Expense Related Terms
Cengild Medical Bhd Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Cengild Medical Bhd's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-3.39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of RM-3.39 Mil mean?
Cengild Medical Bhd (XKLS:0243) has a Other Operating Expense of RM-3.39 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Cengild Medical Bhd and its competitors.
Is Cengild Medical Bhd's Other Operating Expense too high?
Cengild Medical Bhd's current Other Operating Expense is RM-3.39 Mil. Overall, Cengild Medical Bhd has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's Other Operating Expense compare to HCA and THC?
Cengild Medical Bhd's Other Operating Expense of RM-3.39 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Cengild Medical Bhd and its competitors. Cengild Medical Bhd's current Other Operating Expense is RM-3.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.19 — trading 34.5% below its estimated fair value. The current Other Operating Expense is RM-3.39 Mil. Cengild Medical Bhd's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current Other Operating Expense is RM-3.39 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?
Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued.
The current stock price of RM0.19 is trading 34.5% below its estimated GF Value™ of RM0.29.
GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0243:
Other Operating Expense: RM-3.39 Mil
GF Value™: RM0.29 vs. price of RM0.19 (34.5% below fair value)
No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
66GF Score
Get the complete analysis for XKLS:0243
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0243 has been successfully added to your 
